| Financial Year |
March 31 2023 |
| Monetary Funds |
12,303,314,799.46 |
| Held-for-trading Financial Assets |
4,459,125,415.79 |
| Notes Receivable |
246,712,652.99 |
| Accounts Receivable |
1,685,727,787.00 |
| Advances to Suppliers |
70,427,025.03 |
| Other Receivables |
1,170,056,768.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
609,209,224.04 |
| Inventories |
242,994,121.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
850,911,074.16 |
| Other Current Assets |
193,385,491.31 |
| Total Current Assets |
21,222,655,135.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,617,429,169.49 |
| Long-term Equity Investment |
93,142,161,218.98 |
| Investment Properties |
5,078,723,082.96 |
| Fixed Assetes |
31,672,908,906.91 |
| Under-construction Projects |
2,464,228,985.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,183,419,167.08 |
| R&D expenses |
13,120,478.53 |
| Goodwill |
6,448,739,235.22 |
| Long-Term Deferred and Prepaid Expenses |
968,960,172.05 |
| Deferred Income Tax Assets |
433,911,215.96 |
| Other Non-Current Assets |
1,183,705,718.06 |
| Sub-Total of Non-Current Assets |
177,378,132,524.48 |
| Total Assets |
198,600,787,660.07 |
| Short-Term Loans |
6,457,871,100.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
659,724,322.27 |
| Accounts Received In Advance |
13,518,159.74 |
| Employee Compensation Payable |
590,230,462.57 |
| Taxes Payable |
957,160,598.91 |
| Interest Payable |
-- |
| Dividend Payable |
275,643,677.79 |
| Other payables |
1,875,936,638.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,363,621,116.77 |
| Other Current Liabilities |
3,153,298,331.94 |
| Sub-Total of Current Liabilities |
25,204,601,444.13 |
| Long-term Loans |
13,331,788,460.38 |
| Bonds Payable |
18,948,133,988.72 |
| Long-Term Accounts Payable |
3,605,970,588.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
40,845,351.20 |
| Deferred Income Tax Liabilities |
4,933,657,960.25 |
| Other Non-Current Liabilities |
178,359,757.34 |
| Sub-Total of Non-Current Liabilities |
43,598,678,536.08 |
| Total Liabilities |
68,803,279,980.21 |
| Paid-In Capital(Or Share Stock) |
2,499,074,661.00 |
| Capital Surplus |
34,846,694,340.27 |
| Surplus Reserve |
1,001,917,449.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
17,558,245,367.28 |
| Minority Stockholder's Interest |
74,528,417,802.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
55,269,089,877.11 |
| Owner's Equity（Stockholder's Equity） |
129,797,507,679.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
198,600,787,660.07 |
